Introduction. Current treatments for pain have limited benefits and worrying side effects. Some studies suggest that pain is reduced when clinicians deliver positive messages. However, the effects of positive messages are heterogeneous and have not been subject to meta-analysis. We aimed to estimate the efficacy of positive messages for pain reduction.
INTRODUCTION
Chronic and acute pain are common, debilitating, and costly conditions. One hundred million people in the United States alone suffer from chronic pain, and treatment costs exceed an estimated $250 billion per year, which is a considerable burden on the US economy in terms of lost productivity [1] . Reliable estimates of the expenditure for acute pain are not available, but the market for pharmacological treatments for acute pain is believed to be large [2] . Analyses of non-steroidal anti-inflammatory drug treatment of pain suggest that, when taken alone, these drugs have very modest effects [3] . Opioids and intra-articular corticosteroids may have more substantial short-term benefits, but are usually accompanied by more serious adverse effects and therefore an unattractive long-term treatment option [4, 5] . The pursuit of safer and more effective pain treatments is fraught with difficulties, but there are promising strategies readily available to enhance our current therapeutic efforts [6] .
Increasing evidence from clinical trials suggests that clinicians can enhance pain relief by delivering positive messages that modulate patients' expectations and experience of pain [10, 11, 12] . The efficacy of expectation-inducing interventions was tested in one trial in which the patient was impelled to believe that "the medication was a potent painkiller [and] that their pain was going to subside within a few minutes" [13] . In another trial, patients were induced to believe that the medication they were about to receive was a groundbreaking drug that "recently became available in the Netherlands…[t]his drug, according to my experience, is very effective and will decrease the pain quickly after taking it" [10] . In both trials, patients who received positive messages experienced less pain than those who did not. These results indicate 5 that expectation-inducing interventions have a considerable effect on the outcome of pain treatments. Specifically, the way practitioners deliver positive messages is a key component of expectation-inducing interventions and is therefore likely to be an important part of multipronged treatment efforts for clinical pain.
The main mechanism explaining how positive messages enhance pain is likely to involve the brain's reward system, which could produce a physiological response to pain that prompts the patient's body to produce endogenous opioid analgesia [15] .
Pain relief interventions that use positive messages could be mediated through similar mechanisms to drug interventions. There is compelling evidence to support the role of positive messages in reducing anxiety, a condition closely related to pain [16] and evidence to support the role of expectation-inducing interventions in reducing stress and improving well-being in patients suffering from chronic disease [17] . Crucially, enhancing patients' own pain relief mechanisms may be more effective than administering opiate-related drugs. Expectation-inducing methods of pain relief may provide the additional benefit of reducing side effects of drug treatment, such as withdrawal symptoms, addiction, and drug abuse. Understanding brain and nervous system functioning in the production of pain relief using positive messages is an important step in the scientific understanding of core mechanisms and treatments for pain-related conditions, for which there is no cure.
An early systematic review and meta-analysis of clinical studies investigated the extent to which positive messages can induce pain relief in patients [18] . However, several new trials have been published since this study was published, including a recent extensive review by Mistiaen et al. [19] . However, Mistiaen et al. chose not to pool the results of expectation-inducing interventions and therefore did not address the magnitude of response to verbal suggestions by generating an effect size.
Quantitative synthesis of data is required to generate a pooled estimate and confidence intervals (CIs) for treatment effects of interventions, even in cases where the pooled effect needs to be interpreted with caution owing to moderate heterogeneity (which was judged to be the case by Mistiaen et al. [19] ). However, data pooling is important to generate power calculations for future high-quality trials that may resolve heterogeneity issues [20, 21] . This allows the possibility of investigating the mechanisms that contribute to variability in study results [22] . Thus, building on the Mistiaen et al. review [19] , the present study attempts to provide a quantitative assessment and a meaningful interpretation of the efficacy of positive messages for clinically relevant pain.
Another review conducted by Peerdemann et. al. investigated the potential benefits of positive messages or imagery or conditioning and found a positive effect. [14] However the Peerdeman study included experimental pain, they included studies with a high risk of bias, and they combined positive messages with other treatments (conditioning and imagery). Hence the aims of the Peerdeman et al. study were different and it does not provide an unbiased estimate of the effects of practitioner positive messages, whereas ours does.
Aims and Objectives
We aimed to provide a pooled estimate of the effect of delivering positive messages on patient pain.
METHODS

Eligibility criteria
We included randomized trials of the effects of positive messages in a subset of the studies included in a recent systematic review of context factors for treating pain [19] .
The review did not pool the results and was also potentially confounded by the inclusion of non-randomized studies. The protocol, eligibility criteria, information sources, and study selection were reported previously [19] . Reflecting the variety of communication styles within clinical practice, we included trials comparing the effects of positive messages with neutral or negative control [23] .We also included studies comparing a neutral message (as would be provided as part of standard care) with a negative message, since these were relatively positive. However we excluded these in a sensitivity analysis. Trials were excluded if an interpreter or translator was used to induce the positive message or if the interaction between patients and care providers was not face-to-face.
Search strategy
The following electronic databases were searched from their start date to June 2015:
CINAHL, Controlled-trials.com, EMBASE, LILACS, OpenGREY, PROQUEST Dissertations, PsycINFO, PubMed, Sociological Abstracts, the Cochrane Central Register of Controlled Trials, Web of Science. Reference lists of relevant included studies were also searched.
Outcome measures: primary outcome
Our primary outcome measures were patients' self-reported pain scores, most commonly patients' perception of pain intensity reported on a visual analogue scale (VAS), and (to a lesser extent) observer-reported outcomes (such as physiological changes or observer-reported perceived pain) [24, 25] . We only identified one eligible study with dichotomous outcomes.
We used the primary outcome chosen by study authors where possible. If there was more than one primary outcome, or it was unclear, we chose the one most relevant to patients and provided a rationale for our choice. For example, longer-term follow-up (weeks rather than hours) is more likely to be clinically relevant. We contacted authors by email if data required for pooling was not included in published reports.
Data extraction and management
We did additional data extraction as there was insufficient data extracted from the Mistiaen et al. review [19] . Because it was crucial to our analysis we also confirmed the risk of bias assessments by re-conducting the risk of bias. Two authors (from JH, AM, and TF) independently extracted data and assessed the risk of bias in accordance with the Cochrane Handbook guidelines [26] . Discrepancies were resolved by discussion with another author (PM). The extracted data included study design, types of participant, description of intervention and intervention components, description of comparison group, completeness of outcome data, outcome measures, country, and funding source. To investigate possible bias, we recorded data on random sequence generation, allocation sequence concealment, blinding of participants and personnel, blinding with respect to outcome assessment, completeness of outcome data, selective outcome reporting, and other sources of bias.
Impact of bias
Studies were deemed to have a high risk of bias if they were scored as having a high or unclear risk of bias for either sequence generation or allocation concealment. This is because empirical studies have shown that these characteristics influence outcomes [27, 26] . To assess publication bias, we used a funnel plot and investigated funnel plot asymmetry using the trim-and-fill method [28, 29] .
Synthesis of results
For continuous measures, we analyzed data based on the mean, standard deviation, and number of participants. Where data were not reported in a format suitable for pooling, we reported outcomes narratively. Where possible, we made assumptions to allow the data to be included in the analysis, such as assuming a normal distribution, using the median to estimate the mean, and estimating the standard deviation as 0.75 times the inter-quartile range. For studies that did not report the number of individuals randomized to each group, we assumed that an equal proportion of participants were randomized to each group. If the standard deviation at follow-up was not reported, we used the standard deviation at baseline. We used GRABIT software to extract data presented in graphical form (Matlab Central, 2015) . Because of the variety of pain measures used, we calculated standardized mean differences (SMDs), using 95% CIs and P-values for the difference between groups. All analyses used a random effects model.
Assessment of heterogeneity
We anticipated heterogeneity in terms of intervention modalities, conditions, outcome measures, patients, and effect sizes, and therefore used a random effects model for the meta-analysis. Where studies were sufficiently similar to allow pooling of data, quantified heterogeneity was assessed using the I 2 statistic; an I 2 value of 50% or more was interpreted as indicating a substantial level of heterogeneity. Because of the study aims was to quantify the efficacy of positive messages to estimate potential benefits and make comparisons with other treatments, we pooled data despite substantial heterogeneity and noted the limitations of relying on the estimate (Higgins and Green, 2011).
Subgroup /sensitivity analyses
We conducted one pre-planned subgroup analysis that excluded studies with a high risk of bias. This was to establish the least biased estimate possible. We also conducted several exploratory subgroup analyses that were not pre-planned:
1. Exclusion of studies for which we had to make assumptions about the data to obtain poolable data, to test whether our assumptions affected the results.
2. Isolation of studies that measured the effects of expectations on chronic and acute pain, to detect differences in the effects of positive messages on different types of pain.
3. Examination of the effects of positive messages in specific conditions (those that had more than one study investigating them), to detect differences in the effects of positive messages on different types of pain.
4. Exclusion of studies that measure pain as part of a composite outcome, to detect differences in the effects of positive messages on different types of pain outcomes.
5. Exclusion of studies that compared neutral vs. negative or positive vs.
negative messages, to detect differences in the effects of positive messages in different types of studies.
6. Exclusion of outlier studies, to detect an effect size that was not unduly influenced by an anomalous result.
Statistical software used
Analysis was carried out with the 'meta' package in R. (Schwarzer, 2014 , R Core
Team, 2014)
RESULTS
Sixteen studies (1703 patients) within the systematic review met our inclusion criteria [33, 13, 10, 34, 35, 36, 12, 37, 38, 39, 40, 25, 41, 42, 43] . These studies included a variety of interventions (see Tables 1 and 2 ). Twelve of these (1426 patients) had sufficient data for meta-analysis [13, 10, 34, 35, 37, 38, 40, 25, 41, 42, 43] . One study report [13] conveyed results for two trials, which were treated separately.
[ Tables 1 and 2 about here]
We could not extract suitable data for meta-analysis from four studies [33, 36, 12, 39] , mostly because no measure of variability of the primary outcome was reported (and attempts to obtain this data from the authors failed). The risk of bias was judged as high in 10 of the 16 studies included (see Figure 1 ) [33, 13, 10, 34, 35, 36, 37, 39, 40] .
Pain intensity was measured directly using a VAS in most of the studies, and as part of a composite outcome in two studies [37, 38] .
[ Figure 1 about here]
Continuous outcomes
For the continuous outcome measures, the pooled estimate of the SMD was −0.31 [ Figure 2 about here]
Subgroup analysis
Excluding studies for which we had to make assumptions about the data to pool results, [13, 10, 34, 35, 37, 42, 43] the effect was −0.15 (95% CI −0.31 to 0.02, P = 0.08, I 2 = 0%). Excluding studies that measured pain as part of a composite outcome [37, 38] , the pooled estimate was −0.32 (95% CI −0.68 to 0.04, P = 0.08, I 2 = 85%).
Excluding studies that compared neutral versus negative [13, 34] or positive versus negative suggestions [42] , the pooled estimate was −0.14 (95% CI −0.43 to 0.14, P = 0.33, I 2 = 72%). For studies that measured chronic pain, the effect size was −0.10 (95% CI −0.25 to 0.05, p=0.18, I 2 = 0%) and in studies measuring acute pain, it was −0.49 (95% CI −1.04 to 0.07, P = 0.08, I 2 = 89%). For studies of a single condition (postoperative pain), the effect was positive but not statistically significant: [13, 43] −0.79 (95% CI −2.31 to 0.72, P = 0.30).
We conducted an exploratory analysis that excluded outliers in which we repeated the meta-analysis after removing each study separately [44] . This produced point estimates of the effect size that varied from −0.22, 95% CI −0.50 to 0.07 (omitting [13] ) to −0.39, 95% CI −0.68 to −0.10 (omitting [43] ); the corresponding P-values varied between 0.13 to 0.009. As expected from Figure 1 , the studies that appeared to 14 have the most influence on the pooled estimate were [13, 45, 42, 43] . However, we found no substantive reason to exclude any of these studies from our primary analysis.
Assessment of risk of bias within studies
When studies with a high risk of bias were excluded, the effect of positive messages remained positive but not statistically significant. [40] . Other sources of bias included inadequate description of methodology [13] and "floor effects" leading to inability to detect treatment effects [39] .
Publication bias
Visual inspection of the funnel plot indicated the possibility of publication bias, with two smaller studies having the largest effect sizes [45, 13] . Investigation of funnel plot asymmetry using the trim-and-fill method [46] led to a small attenuation in the pooled estimate, to −0.22, 95% CI −0.53 to 0.09, P = 0.17, with the method indicating the possibility of a missing study with a large positive effect size (effectively balancing the result of one of Benedetti's studies). Egger's test of funnel plot asymmetry gave a non-significant P-value of 0.31 [29] . Although we note the relatively large effect size observed in the two Benedetti studies, considering both these results and the visual inspection of the funnel plot, we did not find compelling evidence of publication bias. However, publication bias is a potential problem with all evidence syntheses [47, 48] .
DISCUSSION
Summary of evidence
This is the first meta-analysis of randomized trials of positive messages for patient pain. Although the effects of positive messages are generally encouraging, contrary to what has been reported in previous systematic reviews [49, 18] , they are not unambiguously so. When non-randomized trials are excluded from analysis, the effects are small. Our subgroup analyses (in which we excluded studies with a high risk of bias, investigated chronic and acute pain individually, and investigated postoperative pain individually) showed that the benefits of positive messages persisted but were not always statistically significant. Our meta-analysis is also the first to provide a likely effect size which could be used to make power calculations for future, more definitive (higher quality) randomized trials. Assuming a typical standard deviation of between 1 and 2 units, our review demonstrated a pooled effect size estimate of approximately half of 1 point on a 10-point VAS. This falls short of the 1 to 2-point reduction deemed to be clinically relevant [50] . We found no reason to believe that the effects of positive messages are only beneficial in the short term.
Consistency with existing evidence
Several systematic reviews of placebos (which can include positive messages) have shown placebo to be effective in treating pain [51, 52, 53, 54] . However, the delivery of placebo interventions includes more than positive messages; they also include the effects of a sham intervention [55] and classical conditioning [56] .
Comparison of positive messages with drug effects
Although some drugs have a substantial clinical analgesic effect [57] others do not.
Some drug interventions for treating dental pain [58, 59] , a condition investigated in three of the included studies [24, 36, 37] , knee pain [60] , neuropathic pain, and low back pain [61] revealed effect sizes similar to those found in our study.
Pharmacological interventions may be more likely than positive messages to have adverse side effects [62, 61] . Although our preliminary analysis suggests that they are similar, at this stage, a robust comparison of positive messages with drug effects is not possible.
Comparisons between the effects of positive messages with drugs must be treated with caution. This is because recent estimates of analgesic efficacy use the Oxford League Table [63] , which is not straightforwardly translatable to the continuous VAS measures typical of studies in this review. Our effect size comparisons are based on older effect estimates of analgesic drugs compared with placebo.
Strengths and limitations
This is the first study that quantifies the efficacy of positive messages for treating pain.
There are several limitations to this meta-analysis. The risk of bias was high in many of the studies and the effect size estimate was reduced in subgroup analyses that excluded these studies. There was also some evidence of publication bias. The included studies were also heterogeneous, both statistically and in terms of the interventions. Statistical heterogeneity remained in most cases even after subgroup analyses. This was expected owing to the wide range of interventions, patients, settings, and practitioners. Our use of a random effects model partly addressed this problem.
Heterogeneity of the control interventions could have influenced the effect in either direction. As the effects of positive messages were estimated by subtracting the effects in the control groups from effects in the treatment groups, Hawthorne effects in the control group might have reduced the effect size. A recent systematic review suggested that "untreated" (neutral) control groups in clinical trials benefit from Hawthorne effects [64] . If so, then the effects of positive messages revealed by our study are an underestimate. Our decision to pool studies with different types of controls reflects clinical practice, in which caregivers have a range of consultation styles. The decision to pool results despite the high heterogeneity was also justified because all but one of the studies [23] revealed results consistent with a positive effect.
Reporting bias in the individual studies might have arisen because of the difficulty of blinding caregivers and participants. However, outcomes were assessed by blind observers in two of the included studies [33, 25] and the effects of positive messages were statistically significant in both of these.
Finally, two dangers may arise when implementing the results of these studies. First, if there is a large discrepancy between the patient's experience of pain and what the doctor tells the patient they will feel, the patient may adjust their beliefs to develop a negative expectation (and a subsequent "nocebo" effect) [65] . Delivering an overly positive message that does not match the patient's experience may also threaten the patient/doctor relationship, as the patient may perceive that the doctor is deceiving them [66] . Hence future trials in this area must consider likely realistic prognoses and ensure that any positive messages delivered by clinicians are realistic and nondeceptive.
Conclusions and implications
Positive messages appear to be moderately effective for treating pain. Patients are likely to benefit from positive messages, either alone or together with other treatments.
Limitations to the study, most notably heterogeneity, warrant caution when interpreting the results. However, given the lack of serious harms, the ease of implementation, and the potential benefit to the many patients suffering from pain, clinicians are warranted in implementing the results of this review by delivering (realistic and non-deceptive) positive messages to their patients. Future research is now required to investigate the most efficient, ethical and cost-effective strategies for clinicians to maximize the benefits of positive framing for treating pain. Further work is also required to investigate independent and interactive effects of positive messages and treatments.
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There are no conflicts of interest to declare. Patients were told; "a procedure involving music has been effective in suppressing pain in 5000 dental operations." They were then given music and told: "This new procedure is quite simple. We let you listen to music tapes you particularly like over headphones, and most crucial, we let you make changes in the volume any time you feel any particular increase in tension, discomfort, anxiety, or pain. You do this by moving a dial we've located on your chair up and down." Turning the dial actually moderated the volume slightly, and patients were told that variations in volume would help them attend to the music.
Benedetti 2003a
The open administration of morphine was performed at the bedside by a doctor, who told the patients that the medication was a potent painkiller, according to routine clinical practice. In other words, the patients were informed that their pain was going to subside within a few minutes.
Benedetti 2003b
De Craen 2001
"This is a medication that recently became available in the Netherlands. This drug, according to my experience, is very effective and will decrease the pain quickly after taking it." Dutt-Gupta 2007 "I am going to apply the tourniquet on the arm. As I do this many people find the arm becomes heavy, numb and tingly. This allows the drip to be placed more comfortably." Goodenough 1997 "We are trying out a new special cream. I am going to put some cream on your arm that might make it (the needle) hurt less. Kincheloe 1991 Patients were instructed that the topical aesthetic (in fact a placebo) would numb them and make the injection a lot less painful. Knipschild 2005 (After ascertaining there was no serious disease) patients were told: "You will be better within a week or so." Litt 1993 Patients were told that their relaxation efficacy was high by the experimenter. The experimenter's positive suggestion was reinforced by (false) biofeedback which appeared to confirm the patients' ability to relax. Little 2001 A booklet provided to patients gave positive messages: "you can ease your pain" and "most people do get better within 4 weeks." Petersen 2012
Participants were told: "An active medication that has been shown to be effective for some types of pain will be tested." The active medication was given in full view of the patients, and the patients were told: "The agent you have just been given is known to powerfully reduce pain in some patients." Petersen 2014
The intervention (placebo or treatment) was administered openly (as opposed to covertly for the control patients). Ronel 2011 "Mrs./Mr. XYZ, we are now injecting a drug through the catheter which will widen your coronary vessels. This procedure will improve the blood flow in your heart. This drug is very effective and starts its action immediately. It is possible that you might feel some agreeable warmness or formication after only a few seconds." Suarez-Almazor 2010 "I think this will work for you," "I've had a lot of success with treating knee pain," and "Most of my patients get better." Varelmann 2010 "We are going to inject the local anesthetic that will numb the area where we are going to do the epidural/spinal anesthesia and you will be comfortable during the procedure." "The PCA pump was great in treating pain, especially for people who like you underwent abdominal surgeries", "You took a correct decision on using a PCA pump for your postoperative pain", and "The PCA pump was very effective in removing the postoperative pain affliction."
